fluorodeoxyglucose f18 has been researched along with methotrexate in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (3.85) | 18.2507 |
2000's | 10 (19.23) | 29.6817 |
2010's | 37 (71.15) | 24.3611 |
2020's | 3 (5.77) | 2.80 |
Authors | Studies |
---|---|
Fischman, A; Palmer, WE; Polisson, RP; Rosenthal, D; Rubin, R; Schoenberg, OI; Simon, LS | 1 |
Golding, R; Hoekstra, OS; Ossenkoppele, GJ; Teule, GJ; van Lingen, A | 1 |
Aärimaa, T; Harila-Saari, A; Kähkönen, M; Korhonen, T; Metsähonkala, L; Minn, H; Norvasuo-Heilä, MK; Ruotsalainen, U; Salmi, TT; Solin, O; Suhonen-Polvi, H; Utriainen, T | 1 |
Klockgether, T; Paus, S; Pötzsch, B; Risse, JH; Wüllner, U | 1 |
Bares, R; Bartusek, G; Dittmann, H; Dohmen, BM; Kehlbach, R; Pritzkow, M; Sarbia, M | 1 |
Kawai, N; Masada, T; Matsumoto, Y; Nagao, S; Tamiya, T | 1 |
Bar-Shalom, R; Eilam, O; Hamoud, S; Hayek, T; Rozin, A; Zalts, R | 1 |
Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; O'eill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ | 1 |
Hall, JK | 1 |
Fujimoto, T; Hamada, K; Hashimoto, N; Hatazawa, J; Inoue, A; Myoui, A; Tomita, Y; Yoshikawa, H | 1 |
Endo, K; Hamamoto, K; Higuchi, T; Kanazawa, T; Oriuchi, N | 1 |
Chang, CH; Chang, TJ; Chang, YJ; Ho, TY; Hsiang, CY; Lee, TW; Lin, WJ; Yu, CY | 1 |
Agostinelli, C; Baccarani, M; Broccoli, A; Castellucci, P; Derenzini, E; Fanti, S; Fina, MP; Gandolfi, L; Lopci, E; Pellegrini, C; Pileri, S; Stefoni, V; Venturini, F; Zinzani, PL | 1 |
Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C | 1 |
Eguchi, K; Hayashida, T; Izumi, Y; Kawakami, A; Koga, T; Makiyama, J; Migita, K; Miyashita, T; Nishino, Y; Tamai, M | 1 |
Iwasaki, M; Oshima, K; Sakaura, H; Yamashita, T; Yoshikawa, H | 1 |
Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Quirini, F; Stefoni, V; Zinzani, PL | 1 |
Banerjee, D; Bertino, JR; Blasberg, RG; Cai, S; de Stanchina, E; Kochetkov, T; Moroz, MA; Nair, J; Schwartz, GK; Serganova, I; Shamis, M; Wu, J | 1 |
Hosokai, R; Imai, C; Imamura, M; Iwabuchi, H; Takachi, T; Uchiyama, M; Yoshida, S | 1 |
Arima, N; Fukuda, K; Kishi, H; Tsuda, H | 1 |
Hagiwara, S; Hirai, R; Ito, K; Kitahara, H; Kubota, K; Masuda-Miyata, Y; Minamimoto, R; Miwa, A; Morooka, M; Tanimura, A | 1 |
Hirata, K; Imamura, M; Kuramoto, R; Oridate, N; Suzuki, S; Takei, T; Tamaki, N; Yamada, Y | 1 |
Ambrogi, V; Cavalieri, E; Cox, MC; Lanni, V; Marchetti, P; Monarca, B; Pelliccia, S; Scopinaro, F; Spiriti, MA | 1 |
Adrada, BE; Carkaci, S; Whitman, GJ | 1 |
Al Jammaz, I; Al-Hokbany, N; Al-Otaibi, B; Amer, S; Okarvi, S | 1 |
Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD | 1 |
Danga, A; Hemmaway, CJ; Igbokwe, U; Radunovic, A | 1 |
Kappert, U; Mahlmann, A; Ouda, A; Pfluecke, C; Simonis, G; Weiss, N | 1 |
Honne, K; Iwamoto, M; Minota, S; Nagashima, T; Nagatani, K; Onishi, S | 1 |
Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS | 1 |
Arzu, I; Dabaja, BS; Fayad, LE; Hagemeister, FB; Hess, K; Kedir, A; Mawlawi, O; Medeiros, LJ; Oki, Y; Podoloff, DA; Reed, VK; Rodriguez, A; Shihadeh, F; Wogan, CF | 1 |
Alessi, A; Biasoni, D; Catanzaro, M; Crippa, F; Farè, E; Giannatempo, P; Gianni, AM; Maffezzini, M; Mariani, L; Miceli, R; Necchi, A; Nicolai, N; Padovano, B; Piva, L; Raggi, D; Salvioni, R; Serafini, G; Sonpavde, G; Stagni, S; Torelli, T | 1 |
Balzarotti, M; Brusamolino, E; Cabras, MG; Cavalli, F; Ceriani, L; Davies, A; Ferreri, AJ; Finolezzi, E; Giovanella, L; Johnson, PW; Lopez-Guillermo, A; Martelli, M; Montoto, S; Pileri, SA; Rigacci, L; Salvi, F; Stelitano, C; Vitolo, U; Zinzani, PL; Zucca, E | 1 |
Chan, WK; Huang, B; Khong, PL; Kwong, YL; Lee, EY | 1 |
Nguyen, T; Vandergheynst, F | 1 |
Arita, M; Furuta, K; Hotta, M; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Nishiyama, A | 1 |
Kaneko, T; Kobayashi, T; Okamura, K; Okura, C; Takagishi, K; Takeuchi, K; Tsushima, Y; Yonemoto, Y | 1 |
Nguyen, TT; Parker, BJ; Yachoui, R | 1 |
Eiber, M; Einspieler, I; Thürmel, K | 1 |
Hattori, N; Hirata, K; Kikuchi, Y; Kobayashi, K; Manabe, O; Oyama-Manabe, N; Tamaki, N; Toyonaga, T; Watanabe, S | 1 |
Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
Franzen, D; Greutmann, M; Kolios, A; Liebscher, F; Pfammatter, T | 1 |
Imai, Y; Ishikawa, T; Kazuma, Y; Matsuoka, R; Ochi, Y; Ono, Y | 1 |
Almquist, H; Bläckberg, M; Cwikiel, M; Gudjonsson, S; Kollberg, P; Liedberg, F; Lyttkens, K; Patschan, O | 1 |
Huh, J; Jo, JC; Kang, EH; Kim, JH; Kim, S; Lee, K; Lee, SW; Park, CS; Park, JS; Ryu, JS; Suh, C; Yoon, DH | 1 |
Ahlquist, P; Ellingsen, T; Gram, SB; Hess, S; Høilund-Carlsen, PF | 1 |
Higuchi, Y; Horiuchi, T; Kimoto, Y; Maeda, T; Tanoue, R; Tokunou, T; Tomonari, K | 1 |
Asano, T; Hazama, M; Honda, A; Ishii, S; Kanno, T; Kobayashi, H; Migita, K; Mori, N; Sato, S; Suzuki, E; Suzutani, K; Watanabe, A; Watanabe, H; Yashiro, M | 1 |
Benn, BS; De Marco, T; Gerstenfeld, EP; Hsia, HH; Janmohamed, M; Klein, L; Koth, LL; Lee, BK; Moss, JD; Murray, TO; Pampaloni, MH; Parwani, P; Petek, BJ; Rosenthal, DG; Scheinman, MM; Selby, V; Vedantham, V; Zikherman, J | 1 |
Dobashi, H; Kadowaki, N; Kameda, T; Kato, M; Mino, R; Mitamura, K; Miyagi, T; Mizusaki, M; Nakashima, S; Norikane, T; Shimada, H; Sugihara, K; Wakiya, R; Yamamoto, Y | 1 |
Akdim, F; Grutters, JC; Keijsers, RGM; Mathijssen, H; Post, MC; van de Garde, EMW; Veltkamp, M; Vis, R | 1 |
Chow, TK | 1 |
2 review(s) available for fluorodeoxyglucose f18 and methotrexate
Article | Year |
---|---|
Giant-cell arteritis.
Topics: Aspirin; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Interleukin-6; Magnetic Resonance Angiography; Methotrexate; Platelet Count; Radiopharmaceuticals; Ultrasonography, Doppler, Color | 2008 |
Bone and bone marrow involvement in sarcoidosis.
Topics: Adult; Biopsy; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Humerus; Hydroxychloroquine; Ilium; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Patella; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Whole Body Imaging | 2015 |
5 trial(s) available for fluorodeoxyglucose f18 and methotrexate
Article | Year |
---|---|
Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2009 |
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Mammography; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Male; Methotrexate; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2014 |
Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
45 other study(ies) available for fluorodeoxyglucose f18 and methotrexate
Article | Year |
---|---|
Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Deoxyglucose; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucocorticoids; Glucose; Humans; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Prednisone; Synovial Membrane; Tomography, Emission-Computed; Wrist Joint | 1995 |
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxyglucose; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisone; Time Factors; Tomography, Emission-Computed, Single-Photon; Vincristine | 1993 |
Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Age Factors; Antimetabolites, Antineoplastic; Attention; Brain; Brain Diseases; Brain Neoplasms; Child; Cranial Irradiation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Leukocyte Count; Male; Mental Processes; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psychomotor Performance; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Survivors; Tomography, Emission-Computed | 2000 |
Chorea and antiphospholipid antibodies: treatment with methotrexate.
Topics: Adult; Antibodies, Antiphospholipid; Chorea; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Methotrexate; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Early changes in [18F]FLT uptake after chemotherapy: an experimental study.
Topics: Antineoplastic Agents; Artifacts; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Humans; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Cells, Cultured | 2002 |
[Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2004 |
Panaortitis: diagnosis via fluorodeoxyglucose positron emission tomography.
Topics: Aortitis; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Treatment Outcome | 2005 |
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; HIV Seronegativity; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rituximab | 2007 |
Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Methotrexate; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sclerosis; Temporal Lobe | 2009 |
Noninvasive bioluminescent and microPET imaging for the regulation of NF-kappaB in human hepatoma-bearing mice.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinogens; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms, Experimental; Luciferases; Luminescent Measurements; Methotrexate; Mice; Mice, Nude; Mice, SCID; NF-kappa B; Positron-Emission Tomography; Radiopharmaceuticals; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2009 |
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Remission Induction; Retrospective Studies; Vincristine; Young Adult | 2010 |
Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu's arteritis.
Topics: Amyloidosis; Aorta, Thoracic; Biomarkers; Disease Progression; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Positron-Emission Tomography; Prednisolone; Serum Amyloid A Protein; Takayasu Arteritis; Treatment Outcome; Young Adult | 2010 |
Solitary intradural extramedullary lymphoma of the cervical spine.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cervical Vertebrae; Chemotherapy, Adjuvant; Cytarabine; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Rituximab; Spinal Neoplasms; Treatment Outcome | 2010 |
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Time Factors; Vincristine; Young Adult | 2011 |
Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imaging.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; HCT116 Cells; Humans; Immunoblotting; Ki-67 Antigen; Methotrexate; Mice; Mice, Nude; Organophosphates; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Thymidine; Thymidine Kinase; Xenograft Model Antitumor Assays | 2011 |
Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Palatine Tonsil; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Tonsillar Neoplasms; Vincristine | 2011 |
A mass originating from chronic pyothorax in the pleural cavity.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Empyema, Pleural; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Immunochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Pleural Cavity; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Vincristine | 2011 |
Clinical role of FDG PET/CT for methotrexate-related malignant lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Radionuclide Imaging; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Positron-Emission Tomography; Remission, Spontaneous; Tomography, X-Ray Computed | 2011 |
Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2012 |
Case of the season: Large B-cell lymphoma involving both breasts.
Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cytarabine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2011 |
Novel synthesis and preclinical evaluation of folic acid derivatives labeled with (18)F-[FDG] for PET imaging of folate receptor-positive tumors.
Topics: Animals; Biological Transport; Chemistry Techniques, Synthetic; Drug Stability; Female; Fluorodeoxyglucose F18; Folic Acid; Folic Acid Transporters; Humans; Isotope Labeling; KB Cells; Methotrexate; Mice; Mouth Neoplasms; Positron-Emission Tomography | 2012 |
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult | 2012 |
FDG-PET guided diagnosis of vaginal intravascular diffuse large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capillaries; Cyclophosphamide; Fatal Outcome; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Paraproteins; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Vagina; Vascular Neoplasms; Vincristine | 2012 |
Combined immunosuppressive therapy including a TNF-alpha blocker induces remission in a difficult to treat patient with Takayasu arteriitis and coronary involvement.
Topics: Adult; Antibodies, Monoclonal; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Drug Therapy, Combination; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Angiography; Methotrexate; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Takayasu Arteritis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Fluorodeoxyglucose positron emission tomography/computed tomography for diagnostic imaging in relapsing polychondritis with atypical manifestations.
Topics: Antirheumatic Agents; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Methotrexate; Middle Aged; Multimodal Imaging; Polychondritis, Relapsing; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation.
Topics: Age Factors; Aged; Analysis of Variance; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rituximab; Sex Factors; Time Factors; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Vincristine | 2014 |
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Disease-Free Survival; Doxorubicin; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Urinary Bladder Neoplasms; Vinblastine | 2014 |
Pachymeningitis and aortitis in a patient with antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Aorta; Aortitis; C-Reactive Protein; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Meningitis; Methotrexate; Middle Aged; Neck Pain; Positron-Emission Tomography; Shoulder Pain; Steroids | 2014 |
Chronological assessment of airway lesions in relapsing polychondritis by positron emission tomography.
Topics: Adult; Bronchoscopy; Chest Pain; Costal Cartilage; Cyclosporine; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Methotrexate; Multimodal Imaging; Polychondritis, Relapsing; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Trachea | 2015 |
[18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Female; Fluorodeoxyglucose F18; Foot Joints; Hand Joints; Humans; Male; Methotrexate; Middle Aged; Prednisolone; Radiography; Radionuclide Imaging; Retrospective Studies | 2016 |
Fully integrated whole-body [18F]-fludeoxyglucose positron emission tomography/magnetic resonance imaging in therapy monitoring of giant cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Angiography; Male; Methotrexate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult | 2017 |
Takayasu's Arteritis with Isolated Pulmonary Artery Involvement in a Middle-Aged Asian Woman with Hepatitis B and Latent Tuberculosis Infection.
Topics: Angiography, Digital Subtraction; Antitubercular Agents; Antiviral Agents; Azathioprine; Female; Fluorodeoxyglucose F18; Glucocorticoids; Guanine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Isoniazid; Latent Tuberculosis; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Recurrence; Stenosis, Pulmonary Artery; Takayasu Arteritis | 2017 |
Two Cases of Neurolymphomatosis with Fatal Bilateral Vocal Cord Paralysis that were Diagnosed with
Topics: Adult; Animals; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Hoarseness; Humans; Laryngeal Nerves; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Vocal Cord Paralysis | 2017 |
[
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Urinary Bladder Neoplasms; Vinblastine | 2017 |
Interim
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Registries; Retrospective Studies; Survival Rate | 2017 |
[
Topics: Aged; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Methotrexate; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2018 |
Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by
Topics: Aortitis; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Sarcoidosis | 2018 |
The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antirheumatic Agents; Arthralgia; Asian People; Drug Combinations; Female; Fluorodeoxyglucose F18; Glucocorticoids; Hand; Histiocytes; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Positron Emission Tomography Computed Tomography; Prednisolone; Skin; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha; Ultrasonography, Doppler | 2018 |
Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
Topics: Adalimumab; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Cardiomyopathies; Deprescriptions; Drug Therapy, Combination; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Treatment Outcome | 2019 |
FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Methotrexate; Positron Emission Tomography Computed Tomography | 2022 |
Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Methotrexate; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2023 |
Hepatic Superscan in Methotrexate-Associated Lymphoproliferative Disorder.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Liver; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |